A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
Cosmos Health Inc.
COSM
$4M
Mkt Cap
$0.20
-0.05%
Cosmos Health Inc. (COSM) has a 5-year average return on invested capital (ROIC) of -34.2%. This is below average and may indicate limited pricing power.
Cosmos Health Inc. (COSM) has a market capitalization of $7M. It is classified as a small-cap stock.
Cosmos Health Inc. (COSM) does not currently pay a regular dividend.
Cosmos Health Inc. (COSM) operates in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry, within the Consumer Defensive sector.
Cosmos Health Inc. (COSM) reported annual revenue of $54 million in its most recent fiscal year, based on SEC EDGAR filings.
Cosmos Health Inc. (COSM) has a net profit margin of -41.1%. The company is currently unprofitable.
Cosmos Health Inc. (COSM) generated $-8 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
The Company Cosmos Health Inc. was incorporated in 2009 in Nevada and is a diversified, vertically integrated global healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of innovative medicines and repurposing drugs as well as operator of a telehealth platform. As a global company we are harnessing our expertise and stepping up innovation to continue the momentum behind the discovery, delivery, and expanded development of modern pharmaceutical and nutraceutical products. Our Markets We operate in the healthcare sector and particularly in the Pharmaceutical and Nutraceutical businesses. We cover vertically several process phases within the abovementioned sectors, such as research & development, manufacturing, marketing, sales and distribution of products and services.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 60M | 54M | 53M | 50M | 56M | 55M |
| Net Income | -19M | -22M | -26M | -64M | - | 821K |
| EPS | $-0.77 | $-1.17 | $-2.15 | $-33.16 | $-23.74 | $0.06 |
| Free Cash Flow | -7.8M | -8.1M | -17M | -15M | -7.7M | -12M |
| ROIC | -35.7% | -68.7% | -66.0% | -26.4% | - | 24.2% |
| Gross Margin | 11.4% | 7.9% | 8.1% | 11.8% | 14.8% | 14.5% |
| Debt/Equity | 0.41 | 0.54 | 0.41 | 0.25 | 2.54 | -3.90 |
| Dividends/Share | $0.00 | - | - | $0.02 | - | - |
| Operating Income | -14M | -16M | -22M | -7.5M | -4.5M | 2.7M |
| Operating Margin | -23.9% | -28.6% | -40.9% | -14.8% | -8.1% | 4.9% |
| ROE | -80.1% | -73.9% | -71.5% | -162.8% | - | - |
| Shares Outstanding | 35M | 19M | 27M | 18M | 11M | 14M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 902K | 7.6M | N/A | 6.8M | 30M | 37M | 40M | 55M | 56M | 50M | 53M | 54M | 60M |
| Gross Margin | N/A | 100.0% | N/A | 8.9% | 6.5% | 6.5% | 9.2% | 14.5% | 14.8% | 11.8% | 8.1% | 7.9% | 11.4% |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 165K | 533K | 642K |
| SG&A | 56K | 443K | 486K | 794K | 4.9M | 3.6M | 3.3M | 2.1M | 9.2M | 10M | 20M | 12M | 12M |
| EBIT | 289K | 7.1M | -442K | -203K | -4.9M | -1.2M | -256K | 2.7M | -4.5M | -7.5M | -22M | -16M | -14M |
| Op. Margin | 32.0% | 93.0% | N/A | -3.0% | -16.2% | -3.3% | -0.6% | 4.9% | -8.1% | -14.8% | -40.9% | -28.6% | -23.9% |
| Net Income | 247K | 6.0M | -6.7M | -601K | N/A | -9.1M | -3.3M | 821K | N/A | -64M | -26M | -22M | -19M |
| Net Margin | 27.3% | 79.1% | N/A | -8.9% | N/A | -24.4% | -8.3% | 1.5% | N/A | -127.0% | -48.3% | -41.1% | -31.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 1.9M | 0 | 0 | 0 | 0 | 0 | 0 | 292K | 292K |
| Returns on Capital | |||||||||||||
| ROIC | 28.7% | 110.3% | -53.2% | -5.1% | N/A | -21.2% | -1.1% | 24.2% | N/A | -26.4% | -66.0% | -68.7% | -35.7% |
| ROE | N/A | 223.1% | -316.5% | N/A | N/A | N/A | N/A | N/A | N/A | -162.8% | -71.5% | -73.9% | -80.1% |
| ROA | 56.8% | 149.2% | -169.5% | -31.8% | N/A | -43.8% | -13.8% | 1.9% | N/A | -94.0% | -39.1% | -37.2% | -26.7% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 831K | 6.5M | -497K | -2.1M | -8.8M | -1.6M | -4.8M | -12M | -7.1M | -15M | -16M | -7.7M | -7.7M |
| Free Cash Flow | 831K | 6.5M | -541K | -2.1M | -8.8M | -2.1M | -4.8M | -12M | -7.7M | -15M | -17M | -8.1M | -7.8M |
| Owner Earnings | -3.1M | 6.5M | -531K | -2.2M | -9.1M | -1.8M | -5.3M | -12M | -13M | -15M | -17M | -11M | -11M |
| CapEx | 0 | 21K | 44K | 13K | 55K | 503K | 0 | 118K | 581K | 74K | 1.3M | 418K | 120K |
| Maint. CapEx | 0 | 9K | 5K | 9K | 26K | 44K | 234K | 274K | 352K | 103K | 591K | 1.2M | 1.4M |
| Growth CapEx | N/A | 12K | 39K | 3K | 29K | 459K | N/A | 0 | 229K | 0 | 723K | 0 | 0 |
| D&A | 0 | 9K | 5K | 9K | 26K | 44K | 234K | 274K | 352K | 103K | 591K | 1.2M | 1.4M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 372K | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 1.4% | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 1K | 1K | 0 | 200K | 377K | 0 | 100K | 0 | 0 |
| Buyback Yield | 0.0% | N/A | N/A | N/A | N/A | 0.0% | N/A | 0.3% | N/A | N/A | 0.6% | N/A | 0.0% |
| Stock-Based Comp | 3.9M | N/A | 28K | 17K | 339K | 242K | 242K | 0 | 5.9M | 24K | 578K | 1.7M | 2.3M |
| Debt Repayment | 0 | 0 | 0 | 0 | 239K | 3.6M | 366K | 593K | 907K | 1.1M | 1.1M | 0 | 0 |
| Balance Sheet | |||||||||||||
| Net Debt | N/A | 58K | -111K | -1.4M | 1.7M | 7.9M | 1.8M | 15M | 11M | -11M | 11M | 13M | 8.5M |
| Cash & Equiv. | 864K | 447K | 198K | 717K | 783K | 864K | 39K | 628K | 286K | 21M | 3.8M | 315K | 923K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | 146K | 80K | 11M | 5.5M | 2.9M | 3.0M | 1.6M | 1.8M |
| Debt/Equity | -17.15 | 0.09 | -0.07 | -0.04 | -1.07 | -3.46 | -0.33 | -3.90 | 2.54 | 0.25 | 0.41 | 0.54 | 0.41 |
| Interest Coverage | 118.4 | 111.9 | -5.1 | -1.0 | -6.5 | -1.3 | -0.2 | 1.0 | -1.6 | -3.2 | -25.2 | -15.4 | -15.4 |
| Equity | -54K | 5.5M | -1.2M | -1.8M | -3.0M | -3.3M | -6.5M | -4.2M | 4.4M | 39M | 36M | 25M | 23M |
| Total Assets | 867K | 7.2M | 658K | 3.1M | 11M | 21M | 24M | 44M | 49M | 68M | 66M | 54M | 69M |
| Total Liabilities | 921K | 1.8M | 1.9M | 4.9M | 14M | 24M | 30M | 48M | 45M | 28M | 30M | 30M | 46M |
| Intangibles | N/A | N/A | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 242K | 6.3M | -401K | -1.0M | -7.2M | -16M | -20M | -19M | -34M | -66M | -92M | -114M | -123M |
| Working Capital | 335K | 5.5M | -1.4M | -2.2M | -4.2M | -3.9M | -7.1M | 6.5M | 9.9M | 35M | 12M | -296K | -430K |
| Current Assets | 865K | 7.2M | 547K | 2.6M | 9.5M | 18M | 21M | 41M | 40M | 56M | 37M | 25M | 38M |
| Current Liabilities | 530K | 1.8M | 1.9M | 4.9M | 14M | 22M | 28M | 34M | 30M | 22M | 24M | 26M | 39M |
| Per Share Data | |||||||||||||
| EPS | 0.00 | 0.50 | -0.50 | 0.00 | 677,206.00 | -0.68 | -0.25 | 0.06 | -23.74 | -33.16 | -2.15 | -1.17 | -0.77 |
| Owner EPS | -0.25 | 0.54 | -0.04 | -0.87 | -0.37 | -0.14 | -0.40 | -0.86 | -1.26 | -0.85 | -0.62 | -0.56 | -0.33 |
| Book Value | -0.00 | 0.45 | -0.09 | -0.70 | -0.12 | -0.25 | -0.49 | -0.30 | 0.41 | 2.23 | 1.32 | 1.28 | 0.66 |
| Cash Flow/Share | 0.07 | 0.54 | -0.04 | -0.85 | -0.35 | -0.12 | -0.36 | -0.84 | -0.67 | -0.84 | -0.57 | -0.40 | -0.49 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.02 | N/A | N/A | 0.00 |
| Shares Out. | 12.6M | 12.1M | 13.4M | 2.5M | 24.9M | 13.3M | 13.2M | 13.7M | 10.6M | 17.6M | 27.3M | 19.1M | 34.9M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | 18.0 | N/A | N/A | N/A | N/A | N/A | 85.0 | N/A | N/A | N/A | N/A | -0.3 |
| P/FCF | N/A | 16.7 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 29.4 | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | 19.9 | N/A | N/A | N/A | N/A | N/A | N/A | 9.4 | 2.0 | 0.5 | 0.5 | 0.3 |
| Price/Sales | N/A | 17.0 | N/A | 11.6 | 3.0 | N/A | 1.1 | 0.7 | 0.9 | 0.5 | 0.6 | 0.3 | 0.1 |
| FCF Yield | N/A | 6.0% | -0.7% | -2.1% | -6.5% | N/A | -14.5% | -16.7% | -18.6% | -18.6% | -94.9% | -62.6% | -111.8% |
| Market Cap | 0 | 109M | 80M | 102M | 135M | 0 | 33M | 70M | 41M | 80M | 18M | 13M | 7.0M |
| Avg. Price | 0.00 | 10.75 | 7.25 | 6.12 | 7.17 | 0.00 | 3.16 | 3.02 | 4.84 | 1.49 | 2.66 | 0.87 | 0.20 |
| Year-End Price | 0.00 | 9.00 | 5.95 | 8.00 | 10.65 | 0.00 | 2.50 | 5.10 | 3.88 | 4.56 | 1.49 | 0.68 | 0.20 |
Cosmos Health Inc. passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 11.5%. At current prices, the estimated annualized return to fair value is -16.8%.
Cosmos Health Inc. (COSM) has a debt-to-equity ratio of 0.54. This indicates moderate leverage.
Cosmos Health Inc. (COSM) reported earnings per share (EPS) of $-1.17 in its most recent fiscal year.
Cosmos Health Inc. (COSM) has a return on equity (ROE) of -73.9%. A negative ROE may indicate losses or negative equity.
Cosmos Health Inc. (COSM) has a 5-year average gross margin of 11.5%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 12 years of financial data for Cosmos Health Inc. (COSM), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Cosmos Health Inc. (COSM) has a book value per share of $1.28, based on its most recent annual SEC filing.